Drug interaction alerts are posing problems

September 1997

Drug interaction alerts are posing problems for pharmacists.

First, new drugs...and newly recognized interactions...don't show up in the computer databases for 5 to 12 months.

Second, the interactions that are in the computer cause alerts so frequently that they're often ignored.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

How herbs interact with "regular" drugs
Pulmicort Turbuhaler, a new DRY POWDER inhaler for asthma
Osteoarthritis Two unique new treatments for osteoarthritis of the knee
Pediatrics What do you tell a parent who asks if an antibiotic tastes good?
Pediatrics Ritalin (methylphenidate) to children with epilepsy
Pediatrics Efalex Focus, a new dietary supplement for children
Dermatology Now warning patients NOT to use Skin-Cap
Diabetes Rezulin (troglitazone) is now approved for INITIAL therapy of type 2 diabetes
Diabetes Medicare will cover more diabetes supplies and services
Diabetes Allow pharmacists to join together in networks to provide pharmaceutical care SERVICES
Breast Cancer Femara (Fe-MAR-a, letrozole), a new hormonal therapy for advanced breast cancer
Breast Cancer New screening device to help detect breast cancer
Cardiology Nicotine replacement therapy even for patients with coronary artery disease
Actis, a new Rx device for impotence
OTC product called Rejoyn
Ginkgo to try to improve sexual dysfunction caused by antidepressants
Interactions Drug interaction alerts are posing problems
Neurology & Pain Duract (bromfenac) for pain